Europe Prefilled Syringes Market

Europe Prefilled Syringes Market Size (2022 to 2027)

The size of the Europe Prefilled Syringes Market is estimated to be USD 1.10 billion in 2022. This value is further expected to grow at a CAGR of 5.77% and be worth USD 1.46 billion by 2027.

A “prefilled syringe” is a syringe filled with a fixed quantity of a therapeutic drug. It is more accurate, affordable, convenient, sterile, safe, and accessible than traditional drug delivery methods in which vials were used to store pharmaceutical drugs. These vials were prone to dosing errors and contamination, while prefilled syringes have no such drawbacks. As a result, a growing number of healthcare facilities are adopting this format of a parenteral drug delivery system.

Europe prefilled syringes market is progressing aggressively. Europe has its own prefilled syringes market. Rising awareness about safe-injectable syringes, increasing no. of chronic diseases, and adopting biological drugs have increased the prefilled syringes market for patient treatment. Europe Syringes manufacturer always making improvements into syringes technology & their material also. For safety purposes, better and more convenient than before manufacturing prefilled syringes. Prefilled syringes are one of the fastest-growing markets in drug delivery in various countries. It gives benefits to the pharmaceutical packaging industries of Europe. Medical professionals, doctors, practitioners have given better responses to prefilled syringe technology.

This research report on the Europe prefilled syringes market has been segmented and sub-segmented into the following categories:

By Material: 

• Glass Prefilled Syringes
• Plastic Prefilled Syringes

By Type: 

• Conventional Prefilled Syringes
• Safety Prefilled Syringes

By Design: 

• Single-Chamber
• Dual-Chamber

By Application: 

• Vaccines
• Monoclonal Antibodies

By Distribution Channel: 

• Hospitals
• Ambulatory Surgical Centres
• Mail-Order Pharmacies

By Country: 

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Regionally, in 2020, the European prefilled syringes market commanded a substantial global market share. It is expected to remain until the end of the forecast period. The adoption of high safety standards and a considerable number of market players can be attributed to its dominance in the market.

UK, Germany, France are well-developed countries in Europe. UK and Germany have the largest market share prefilled syringes market in Europe. Ipsen UK & Ireland launched the new pre-filled syringes for the Somatuline Autogel. It the specially designed as per the patient-centric. The syringe is used for NHS for the treatment of adult patients with neuroendocrine tumors. Every year, more than 4000 people are diagnosed with neuroendocrine tumors (NET). In Europe, the Dutch hospital is the first to develop re-filled ready-to-use syringes. This machine will reduce mistakes chances.

KEY MARKET PLAYERS:

Companies like Becton Dickinson and Company, Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Inc., Ompi, Catalent, Inc., Weigao Group, Vetter Pharma International GmbH, Nipro Corporation & MedPro Inc. are playing a leading role in the Europe Prefilled Syringes Market.